2014
DOI: 10.1016/j.yjmcc.2014.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
76
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 101 publications
(85 citation statements)
references
References 63 publications
8
76
0
1
Order By: Relevance
“…A similar mechanism was also observed in breast cancer cells (12). Additionally, a recent study on cardiomyopathy demonstrated that oleuropein has a protective effect in doxorubicin-induced cardiomyopathy through the activation of AMPK and suppression of iNOS (11). In the current study, evidence is presented for a role of oleuropein as an inhibitor of cell growth and an inducer of apoptosis, which suggests that oleuropein possesses antitumor activity in HCC.…”
Section: Discussionsupporting
confidence: 78%
See 1 more Smart Citation
“…A similar mechanism was also observed in breast cancer cells (12). Additionally, a recent study on cardiomyopathy demonstrated that oleuropein has a protective effect in doxorubicin-induced cardiomyopathy through the activation of AMPK and suppression of iNOS (11). In the current study, evidence is presented for a role of oleuropein as an inhibitor of cell growth and an inducer of apoptosis, which suggests that oleuropein possesses antitumor activity in HCC.…”
Section: Discussionsupporting
confidence: 78%
“…The primary component of olive leaf extract is oleuropein. Andreadou et al reported that oleuropein is involved in cardiomyocyte metabolism through the activation of AMP-activated protein kinase α (AMPK) and suppression of inducible nitric oxide synthases (iNOS) (11). It has recently been reported that oleuropein may have therapeutic potential in a number of types of cancer, including breast cancer (12), thyroid cancer (13) and colorectal cancer (14), via inhibition of cell growth induction of apoptosis.…”
Section: Introductionmentioning
confidence: 99%
“…Similar biochemical changes have been seen in several other studies (Fouad et al, 2013;Andreadou et al, 2014;Saeed et al, 2015). The elevated levels of MDA and NO, due to the doxorubicin-induced toxicity, were significantly impeded by AcoA treatment.…”
Section: Discussionsupporting
confidence: 87%
“…Our findings show that oleuropein reduces proinflammatory cytokines and increased antioxidant markers. Such findings are similar to those that reported that oleuropein reduced prooxidants and proinflammatory cytokines and increased antioxidant markers in adriamycin cardiotoxicity (Andreadou et al 2014;Andreadou et al 2007) and myocardial ischemia/reperfusion (Andreadou et al 2006;Manna et al 2004) studies.…”
Section: Discussionsupporting
confidence: 91%
“…Such a conclusion receives support from previous studies demonstrating that oleuropein was cardioprotective against acute and chronic doxorubicin-induced cardiotoxicities (Andreadou et al 2014;Andreadou et al 2007) and ischemia-reperfusion injuries (Andreadou et al 2006). The cardioprotective effects of oleuropein have been attributed to several mechanisms such as reduction of oxidative and nitrosative stress (Andreadou et al 2007) as well as antiplatelet (Petroni et al 1995), hypolipidemic (Andreadou et al 2006), and antiinflammatory (Andreadou et al 2014) activities. We, therefore, sought to measure serum levels of SOD, GRx, MDA, IL-1β, and TNF-α to examine the role of oxidative stress and proinflammatory cytokines in the oleuropein's cardioprotective effects.…”
Section: Discussionsupporting
confidence: 53%